Table III.
A, Univariate analysis | ||||
---|---|---|---|---|
Variable | OR (95% CI) | P-value | ||
NLR (≥2.2/<2.2) | 6.84 (1.61–47.58) | 0.00740 | ||
mGPS (1+2/0) | NA | 0.0407 | ||
cT (T1,T2/T3,T4) | NA | 0.0935 | ||
cN (+/-) | NA | 0.0935 | ||
B, Multivariate analysis | ||||
Variable | OR (95% CI) | P-value | ||
NLR (≥2.2/<2.2) | 5.35 (1.21–38.03) | 0.0257 | ||
cT (T1,T2/T3,T4) | NA | 0.175 | ||
cN (+/-) | NA | 0.175 |
OR, odds ratio; CI, confidence interval; NLR, neutrophil to lymphocyte ratio; mGPS, modified Glasgow prognostic score; cT, clinical tumor invasion depth; cN, clinical node status; +, positive; -, negative; NA, not available.